Kyorin And Bayer Enter Into License Agreement For Novel Obstructive Sleep Apnea (Osa) Treatment
16/12/2024 02:40
Dec 16 (Reuters) - Kyorin Pharmaceutical Co Ltd
4569.T :
* KYORIN PHARMACEUTICAL CO LTD - KYORIN AND BAYER ENTER INTO
LICENSE AGREEMENT FOR NOVEL OBSTRUCTIVE SLEEP APNEA (OSA)
TREATMENT:
Source text: ID:nTSxp8395c
Further company coverage: 4569.T BAYGn.DE
(Reporting by Kiyoshi Takenaka)
((kiyoshi.takenaka@thomsonreuters.com;))